Integrated precise temperature regulation and electrophysiology sensing system for nanoplasmonic photothermal cardiac bradyarrhythmia therapy Authors: Jilin Zheng, Zhekun Jia, Yuli Hu, Xuelian Lyu, Saier Huang, Jiaru Fang, Dongxin Xu, Jiong Ding, Ning Hu Published: 2026 ABSTRACT Bradyarrhythmia is a potentially life-threatening disease. Current pharmacological and surgical treatments are limited by side effects and invasiveness, with an urgent need for safer and noninvasive therapeutic strategies. In this study, we develop a multifunctional regulating-sensing platform that integrates precise temperature regulation with simultaneous electrophysiological detection. This platform employs gold nanorods (Au NRs) as nanoplasmonic photothermal effect carriers in combination with integrated serpentine-shaped resistance temperature sensors (RTSs) and a microelectrode array (MEA) device. Under near-infrared (NIR) irradiation, the RTS achieves precise regulation of the therapeutic temperature during nanoplasmonic photothermal therapy (NPT), while the MEA is utilized for dynamic monitoring of electrophysiological signals. The optimization of the RTS structural parameters enhances temperature response sensitivity. Precise modulation of NPT temperature enables restoration of the bradyarrhythmia cardiomyocytes to a normal rhythm, which can be sustained for up to 380 min. Compared with traditional thermal imaging strategy, the RTS-based strategy offers superior temperature resolution, shorter response time, and greater system integration potential, which significantly improves the safety and accuracy of the treatment. This integrated regulating-sensing platform provides an effective pathway for the precise treatment of bradyarrhythmia and holds significant implications in the field of clinical cardiology. Introduction Bradyarrhythmia is a cardiovascular disease characterized by pathological slowing of heart rate or electrical conduction, which can lead to serious clinical consequences, including syncope, heart failure, and even sudden cardiac death1,2. Approximately 8 million individuals worldwide suffer from bradyarrhythmia, and the prevalence increases significantly with age, posing a major threat to elderly populations and individuals with chronic comorbidities1,3–5. Currently, treatment of bradyarrhythmia mainly relies on pharmacological intervention and surgical treatment6,7. Although drugs such as atropine8,9, isoprenaline10,11, and dopamine11,12 can effectively increase heart rate in the short term, their long-term efficacy is limited, and prolonged administration may induce secondary arrhythmias6. Surgical procedures (e.g., cardiac structural correction and conduction system repair) are effective, but highly invasive and technically complicated, with significant interindividual variability that constrains their widespread clinical application13. Electronic pacemakers currently serve as the first-line therapeutic intervention for severe bradyarrhythmia2. However, their long-term applications are limited by postoperative complications such as post-procedural infections, lead dislodgement, device aging, and battery depletion2,14. Therefore, there is an urgent demand for safer, more effective, and durable therapeutic strategies for bradyarrhythmia. In recent years, near-infrared (NIR)-triggered photothermal therapy has shown promising therapeutic applications owing to its high spatial resolution targeting, simplified operation, and lower complication risk15,16. The therapeutic mechanism of photothermal therapy relies on the selective absorption of NIR light via photothermal conversion agents (PTAs), which subsequently convert the absorbed energy into localized heat to target lesion regions17,18. Currently, various types of inorganic PTAs (e.g., gold nanostructures19–21, carbon-based nanomaterials22,23, transition metal chalcogenides24,25,) and organic PTAs (e.g., conjugated polymers26,27, small organic dyes28,29) have been extensively investigated. Among these materials, gold nanorods (Au NRs) are of great interest owing to their excellent biocompatibility and high photothermal conversion efficiency, demonstrating potential application in the field of cardiac rhythm regulation30–33. The stable chemical properties and excellent biocompatibility34 minimize potential cytotoxicity and long-term safety concerns in cardiomyocytes. Moreover, Au NRs exhibit good photostability and chemical inertness under laser irradiation, ensuring consistent and reliable performance during the treatment process. The 808 nm laser closely matches the absorption peak of Au NRs, which enables efficient light absorption and localized heat generation within Au NR-treated cardiomyocytes. Consequently, a relatively low laser power density is sufficient to achieve the desired therapeutic temperature within the targeted cellular region. However, the efficacy of NPT is highly sensitive to temperature. Previous studies have shown that the NPT temperatures below the threshold fail to achieve the desired therapeutic effect, whereas excessively high temperatures may cause irreversible damage32. Therefore, precise temperature regulation and feedback of NPT temperature monitoring system during treatment are critical in cell based assay. Current temperature measurement techniques for biomedical applications include microcalorimetry35, infrared thermal imaging36, fluorescence thermometry37,38, and contact-based electrical temperature sensing39–41. Although microcalorimeters exhibit high sensitivity, their spatial and temporal resolution have significant limitations42. Infrared thermal imaging is widely utilized with the non-contact, noninvasive, and high-throughput properties. However, the accuracy of temperature measurement is markedly influenced by surface emissivity and ambient radiation42. Fluorescent thermometers offer submicron spatial resolution, yet their measurement results are susceptible to interference from environmental factors such as pH and ionic strength, as well as technical challenges including photobleaching of fluorescence probes and instability of the excitation light source43. In contrast, contact-based electrical temperature sensing technology (e.g., thermocouples and thermistors) is beneficial to long-term monitoring applications with their strong noise immunity, fast response speed, excellent measurement accuracy, and superior stability39–41. Thermocouple detectors convert temperature signals into electric potential signals via the Seebeck effect to achieve precise temperature measurement44. However, in highly dynamic thermal environments, the large thermal capacity, low sensitivity, and delayed response of thermocouple probes limit their ability to capture real-time subtle temperature fluctuations45. Conversely, thermistors feature with low heat capacity, high sensitivity, and fast response. Therefore, the development of a thermistor-based temperature regulation system will provide real-time, precise thermal control and feedback in NPT. Herein, we propose a precise and effective therapeutic strategy for bradyarrhythmia based on Au NR-mediated nanoplasmonic photothermal effects. An integrated regulating-sensing system performs the precise temperature regulation, simultaneous electrophysiological detection, and quantitative analysis of electrophysiological parameters such as firing rate and recovery duration (Fig. 1). The serpentine-shaped resistance temperature sensors (RTSs) integrated with a microelectrode array (MEA) are fabricated into a multifunctional device. By utilizing the calibrated resistance-temperature relationship, the RTS realizes precise temperature regulation during NPT, which enables effective intervention in bradyarrhythmia. Moreover, compared with the traditional thermal imaging approaches, the RTS-based strategies demonstrate higher spatiotemporal resolution, improved temperature precision, and enhanced effectiveness in cardiomyocyte rhythm regulation. The integrated regulating-sensing platform achieves effective treatment of bradyarrhythmia through high-precision NPT temperature regulation and offers a versatile tool for advancing cardiac electrophysiology research.Fig. 1Schematic representation of the integrated system for temperature regulation and electrophysiological sensing in nanoplasmonic photothermal therapy (NPT) to treat bradyarrhythmia in cardiomyocytes.The system employs serpentine-shaped resistance temperature sensors (RTSs) for precise temperature regulating and microelectrode arrays (MEAs) for dynamic electrophysiological recording. Compared with an image-based temperature sensing (ITS-based) strategy using a handled thermometer, the RTS-based strategy provides superior temperature modulation precision. Optimization of these strategies, along with analysis of electrophysiological parameters (e.g., firing rate and recovery duration), allows the system to evaluate the impact of precise temperature regulation on photothermal therapy efficacy Schematic representation of the integrated system for temperature regulation and electrophysiological sensing in nanoplasmonic photothermal therapy (NPT) to treat bradyarrhythmia in cardiomyocytes. The system employs serpentine-shaped resistance temperature sensors (RTSs) for precise temperature regulating and microelectrode arrays (MEAs) for dynamic electrophysiological recording. Compared with an image-based temperature sensing (ITS-based) strategy using a handled thermometer, the RTS-based strategy provides superior temperature modulation precision. Optimization of these strategies, along with analysis of electrophysiological parameters (e.g., firing rate and recovery duration), allows the system to evaluate the impact of precise temperature regulation on photothermal therapy efficacy Method Device fabrication A multifunctional device integrated with precise temperature regulation and synchronous electrophysiological detection is fabricated using microfabrication technology. The device utilizes a 6-inch quartz wafer with a thickness of 0.75 mm as the substrate. The RZJ-390PG-30 photoresist (Ruihong Electronic Chemical, China) is first spin-coated at 4000 rpm, followed by soft baking at 110 °C for 1 min and exposure at a dose of 90 mJ/cm² to pattern the electrodes, leads, and pads. Subsequently, the substrate is developed with AZ 300 MIF developer (Microchemicals GmbH, Germany) for 2 min, rinsed in DI water for 1 min, and blow-dried with nitrogen (N2) gas. Titanium (ZhongNuo Advanced Material (Beijing) Technology Co., Ltd, 10 nm) and platinum (ZhongNuo Advanced Material (Beijing) Technology Co., Ltd, 100 nm) layers are deposited via magnetron sputtering and then lifted off in acetone. A 5 μm-thick SU-8 (Kayaku Advanced Materials Inc.) is spin-coated at 3000 rpm and soft-baked at 95 °C for 2 min to serve as an insulating layer. After exposure to a dose of 160 mJ/cm,2 the SU-8 layer is post-exposure baked at 95 °C for 3 min, developed in propylene glycol methyl acetate (PGMEA, Kayaku Advanced Materials Inc.) for 1 min, rinsed in isopropanol for 1 min, blown dried by N2, and hard baked at 150 °C for 30 min. For device assembly, the quartz wafer is diced into small pieces measuring 2 × 2 cm², mounted on a customized printed circuit board (PCB) with polydimethylsiloxane (PDMS, Sygard 184, America) glue, and ultimately, a glass ring is glued to the center of the device for cell culture (Fig. S2). The yield of devices across all fabrication batches is 100%. Optimization and calibration of the resistance temperature sensor A resistance temperature sensor (RTS) integrated within the device features a serpentine-shaped structure. The performance of the RTS is optimized by adjusting the winding numbers (12, 18, 24), line width (4, 6, 8, and 10 μm), and winding spacing (4, 6, 8, and 10 μm). Each design maintains a fixed length of 1000 μm, while the overall width is determined by the specific winding configuration (number, width, and spacing). Temperature-resistance calibration is performed by the two-wire method to systematically evaluate the temperature sensitivity of RTSs with various winding configurations. Specifically, a standard platinum resistance temperature detector (RTD, Omega, America) and the RTSs are immersed in a constant-temperature bath (Fluke 7341, America). The RTD serves as a standard calibration device, and the measured temperature is recorded by a resistance thermometer (Fluke 1529, America) to provide the true temperature values. The temperature-resistance relationship of various RTS configurations is systematically investigated by sequentially adjusting the thermostatic bath within the range of 30 to 50 °C. Primary rat cardiomyocyte culture and staining After disinfection with 75% alcohol, the assembled device is transferred to a clean bench and subjected to UV sterilization. Subsequently, a fibronectin solution (Sigma, USA) is applied to coat the device surface and incubated at 37 °C with 5% CO2 for 2 h to promote cell adhesion. One-day-old Sprague-Dawley rats are disinfected with 75% ethanol, then the ventricular tissues are rapidly excised and rinsed in ice-cold Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific, USA). The ventricular tissue is minced in Hank’s Balanced Salt Solution (HBSS, Thermo Fisher Scientific, USA) and subjected to 11–13 sequential digestions in HBSS supplemented with 0.07% trypsin and 0.05% collagenase II. Following digestion, the tissue is triturated, centrifuged, and resuspended in DMEM supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific, USA). The cell suspension is filtered through a 70 µm cell sieve and then purified by two rounds of 45-minute differential attachment in a cell culture incubator (37 °C, 5% CO2). Finally, cardiomyocytes are seeded onto the assembled device at a density of 3 × 105 cells/mL, and the culture medium is refreshed every 24 h. All protocols complied with the regulations of the Zhejiang University Laboratory Animal Welfare and Ethics Review Committee. To evaluate the viability and morphology of cardiomyocytes cultured on the device, cells are stained with calcein AM (Thermo Fisher Scientific, USA), propidium iodide (PI, Thermo Fisher Scientific, USA), and DAPI (Beyotime, China). The three dyes mentioned above are added to DMEM, and the mixture is incubated with cells at 37 °C under 5% CO₂ for 10 min. Subsequently, the cells are rinsed twice with phosphate-buffered saline (PBS) to ensure complete removal of any unbound dye. Finally, the stained cells are observed under an inverted fluorescence microscope (Guangzhou Mshot Photoelectric Technology Co., LTD., China). Electrophysiological recording Electrophysiological recordings are performed using a custom-developed integrated signal acquisition system when cardiomyocytes exhibit rhythmic spontaneous beating. This system comprises an electrical signal conditioning module, a data acquisition card, and a custom LabVIEW program. The integrated resistance temperature regulating and electrophysiology detection device is attached to the primary electrical signal conditioning module, which incorporates a primary amplifier and a pulse generator, enabling long-term recordings within an incubator. A transmission cable links the primary module with the secondary conditioning circuit and the data acquisition card. The secondary conditioning circuit comprises an integrated filter and a secondary amplifier module. Electrophysiological signals are acquired at a sampling frequency of 20 kHz, bandpass filtered from 1 Hz to 7.5 kHz, and then displayed and stored on a computer via the LabVIEW program. Characterization of device and Au NRs The electrochemical impedance spectroscopy (EIS) measurement of microelectrodes in PBS is characterized by the Vertex. C electrochemical workstation (IVIUM Technologies, Netherlands) with an applied frequency range of 1 Hz–100 kHz. The morphology and particle size of Au NRs are characterized by transmission electron microscopy (TEM, Talos F200S, FEI, America) at an operating voltage of 200 kV. The UV-vis absorption spectra of Au NRs are measured by a UV-vis spectrophotometer (Shimadzu, Japan) in the wavelength range of 400–1200 nm. Moreover, to investigate the effect of NPT at different concentrations of Au NRs, 0.3 mL of Au NRs solution is exposed to an NIR laser (808 nm) for 16 min at a distance of 10.0 cm above the sample solution. A serpentine-shaped RTS is employed to monitor temperature variations during laser irradiation. Nanoplasmonic photothermal therapy After 9 days of culture, the cardiomyocytes exhibit bradyarrhythmia that can serve as a model for NPT. The cell culture medium supplemented with Au NRs (10 µg/mL) is vertically exposed to a NIR laser (808 nm, Changchun New Industry Optoelectronics Technology Co., Ltd., China) at an irradiation intensity of 1.0 W/cm2, with the laser source positioned 10.0 cm above the cells. An integrated RTS is employed to modulate the temperature, and a MEA is utilized to dynamically record the extracellular electrophysiological signals of cardiomyocytes before and after NPT. Temperature regulation (38, 38.5, and 39 °C) is realized by modulating the duration of NIR laser irradiation on the cells during laser exposure. Meanwhile, continuous temperature regulation during irradiation enables the exploration of the optimal temperature for NPT. Signal processing and statistical analysis Signal processing is performed using a custom-developed LabVIEW program. Specifically, amplitude is quantified as the difference between the peak and valley values, while firing rate is defined as the number of action potentials per unit time. The peak detection algorithm implemented in LabVIEW automatically identified the peak and valley points of extracellular action potentials, enabling the extraction of both amplitude and firing rate parameters from multichannel recordings. All experiments are independently repeated at least three times under consistent conditions to ensure scientific rigor and reproducibility. Specifically, for each experimental condition, at least three separate RTS-MEA devices are utilized to mitigate technical variability. During data analysis, the pre-treatment signals serve as an internal control to normalize post-treatment data. The reported sample size (N) corresponds to the total number of valid recording channels obtained from these RTS-MEA devices. All data are presented as mean ± standard deviation (SD). Statistical significance is analyzed by two-way ANOVA using GraphPad Prism 9 (GraphPad Software Inc., USA). The threshold for statistical significance is set at p < 0.05, with significance levels denoted as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001. Results and discussions Establishment and characterization of integrated resistance temperature regulation and electrophysiology sensing system The integrated resistance temperature regulation and electrophysiology sensing system contains RTSs, MEAs, and a regulating-sensing instrument. An integrated RTS-MEA device is fabricated by a microfabrication process (Fig. 2a). Initially, serpentine-shaped patterns, microelectrodes, leads, and pads are defined on the quartz glass substrate using standard lithography. Subsequently, the titanium (Ti, 10 nm) and platinum (Pt, 100 nm) layers are sputtered for adhesion and conductivity enhancement, followed by a lift-off process in acetone to remove residual photoresist. Finally, a 5 μm-thick SU-8 insulation layer is patterned to minimize current leakage from the serpentine-shaped structure and leads, and a 30-μm-diameter circular opening in each microelectrode serves as an effective recording site. Each device features 2 centrosymmetric serpentine-shaped RTSs and 32 microelectrodes (Fig. 2b(i)), with an inter-electrode spacing of 300 μm between adjacent microelectrodes (Fig. 2b(ii)). The detailed layout of the integrated device is shown in Figs. S1 and S2. Moreover, Fig. 2b(iii) illustrates the RTS with a fixed length of 1000 μm and a variable width determined by the number of windings (12, 18, 24), line widths (4, 6, 8, and 10 μm), and spacing (4, 6, 8, and 10 μm). Figure 2b (iv) shows a magnified view of the RTS, which provides the detailed serpentine-shaped structure.Fig. 2Establishment of an integrated resistance temperature regulating-electrophysiology sensing system and characterization of Au NRs.a Fabrication process of the RTS-MEA device. b The fabricated RTS-MEA device: (i) photograph of the overall device; (ii) optical micrograph of the MEA; (iii) optical micrograph of the RTS; and (iv) magnified view of the RTS. c–f Temperature-resistance characteristics for RTSs with different winding configurations, including winding number (12 (blue), 18 (purple), and 24 (red)), line width (L), and spacing (S). c L4S4, d L6S6, e L8S8, f L10S10. g Statistical diagram illustrates the L and S optimization of the RTS with 12 (blue), 18 (purple), and 24 (red) windings (n ≥ 12). h Stability of RTS at room temperature (20.7°C). i Electrochemical impedance spectroscopy of MEA in phosphate-buffered saline. j Transmission electron microscopy image of Au NRs. k UV-vis absorbance spectrum of Au NRs. l Temperature changes in Au NR solutions at various concentrations (5, 10, and 20 μg/mL) during and after 808 nm laser irradiation Establishment of an integrated resistance temperature regulating-electrophysiology sensing system and characterization of Au NRs. a Fabrication process of the RTS-MEA device. b The fabricated RTS-MEA device: (i) photograph of the overall device; (ii) optical micrograph of the MEA; (iii) optical micrograph of the RTS; and (iv) magnified view of the RTS. c–f Temperature-resistance characteristics for RTSs with different winding configurations, including winding number (12 (blue), 18 (purple), and 24 (red)), line width (L), and spacing (S). c L4S4, d L6S6, e L8S8, f L10S10. g Statistical diagram illustrates the L and S optimization of the RTS with 12 (blue), 18 (purple), and 24 (red) windings (n ≥ 12). h Stability of RTS at room temperature (20.7°C). i Electrochemical impedance spectroscopy of MEA in phosphate-buffered saline. j Transmission electron microscopy image of Au NRs. k UV-vis absorbance spectrum of Au NRs. l Temperature changes in Au NR solutions at various concentrations (5, 10, and 20 μg/mL) during and after 808 nm laser irradiation To investigate the sensitivity of RTSs with various winding configurations, a two-wire method is employed to calibrate the temperature-resistance relationship. The detailed geometrical dimensions optimization of RTS is listed in Table S1 and Fig. 2c–f shows the temperature-resistance characteristics of RTSs under different winding configurations. As shown in Fig. 2c, the 24-winding RTS (4 μm line width and spacing) exhibits higher sensitivity, with an average resistance variation rate of 48.2 Ω/°C. In comparison, the 18-winding and 12-winding RTSs show lower rates of 35.4 and 24.6 Ω/°C, respectively. When the line width and spacing increase to 6 μm (Fig. 2d), the resistance change rates for 12, 18, and 24 windings are 16.2, 23.2, and 32.3 Ω/°C, respectively. As the line width and spacing further increase to 8 μm (Fig. 2e) and 10 μm (Fig. 2f), the sensitivity gradually decreases. Specifically, at a line width and spacing of 8 μm, the resistance change rates for 12, 18, and 24 windings are 12.4, 18.3, and 24.5 Ω/°C, while at 10 μm they further decline to 10.0, 14.9, and 19.9 Ω/°C, respectively. Statistical analysis (Fig. 2g) further demonstrates that the RTS with 24 windings, a line width of 4 μm, and a spacing of 4 μm exhibits higher sensitivity (46.5 ± 2.0 Ω/°C; n ≥ 12). To evaluate the stability of RTS with an optimal winding configuration (24-windings, 4 μm line width and 4 μm spacing), continuous measurements are carried out at an average temperature of 20.7 °C. The RTS exhibits outstanding stability with less than 1% variation in temperature sensing over a 1 h period (Fig. 2h), indicating that the measurements are minimally affected by self-heating effects. Moreover, the integrated device is placed in a constant temperature incubator (37 °C, 5% CO₂) for continuous temperature monitoring over a 5-day period to evaluate its short-term stability. The results show that the temperature fluctuations remain minimal throughout the entire testing period (Fig. S3), demonstrating good short-term stability of the RTS. Furthermore, low electrode impedance is crucial for high-fidelity recording of electrophysiological signals. As depicted in Fig. 2i, the impedance spectra show that the microelectrodes have low impedance in phosphate-buffered saline. The structure and properties of Au NRs are systematically characterized to investigate their nanoplasmonic photothermal effects. Transmission electron microscopy (TEM) images reveal that Au NRs have a rod-shaped structure with a smooth surface and uniform size distribution (Fig. 2j). As illustrated in Fig. 2k, the UV-vis absorbance spectrum of Au NRs shows a prominent absorption peak at 808 nm. To further evaluate the photothermal performance of Au NRs, solutions containing different concentrations of Au NRs (5, 10, and 20 μg/mL) are exposed to an 808 nm NIR laser. After 16 min of laser irradiation, the solution temperatures increased to 43.0 ± 2.2 °C (5 μg/mL), 48.0 ± 1.0°C (10 μg/mL), and 52.0 ± 2.5°C (20 μg/mL) (Fig. 2l), respectively, indicating that the Au NRs exhibit excellent photothermal conversion efficiency. Notably, all three solutions returned to their initial temperatures within 10 min after the laser exposure ceased. Based on these results, a concentration of 10 μg/mL Au NRs is determined for the subsequent NPT experiments to balance photothermal efficiency and biocompatibility. Bradyarrhythmia modeling of cardiomyocyte To evaluate the effect of Au NR-mediated nanophotothermal treatment on chronic arrhythmia, we establish a bradyarrhythmia model at the cellular level. As shown in Fig. 3a, primary cardiomyocytes are isolated from the hearts of 1-day-old SD rats and cultured on an integrated RTS-MEA device. After 2–3 days of culture, the cardiomyocytes spread to form a monolayer network and exhibit autonomous rhythmic beating. With the extension of culture duration, cellular senescence is evident by day 9, characterized by slow and irregular beating. The viability of cardiomyocytes cultured on the integrated device is evaluated by live/dead cell staining (Fig. 3b). Microscopic bright-field images reveal that cardiomyocytes are uniformly distributed on the device surface. Live cells are stained green with calcein AM, nuclei are stained blue with DAPI, and dead cells are stained red with PI (Fig. S4). The merged fluorescence images demonstrate that the cardiomyocytes form a continuous monolayer on the device surface.Fig. 3Bradyarrhythmia modeling.a A schematic diagram illustrates the establishment of a bradyarrhythmia model by culturing primary rat cardiomyocytes on RTS-MEA devices. b Bright-field and fluorescent microscopy images of cardiomyocytes cultured on the RTS-MEA device. Green represents living cells, and blue denotes nuclei. c Typical extracellular electrophysiological signals are recorded from cardiomyocytes between days 2 and 9 of culture. Statistical analysis of electrophysiological signal amplitude d and firing rate e in the bradyarrhythmia model. N = 82 (N represents the total number of measured channels); *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. f Poincaré plots analysis of the bradyarrhythmia model. The horizontal axis (ISIn) represents the interval between the current and the previous extracellular action potential, and the vertical axis (ISIn+1) represents the interval between the current and the next extracellular action potential Bradyarrhythmia modeling. a A schematic diagram illustrates the establishment of a bradyarrhythmia model by culturing primary rat cardiomyocytes on RTS-MEA devices. b Bright-field and fluorescent microscopy images of cardiomyocytes cultured on the RTS-MEA device. Green represents living cells, and blue denotes nuclei. c Typical extracellular electrophysiological signals are recorded from cardiomyocytes between days 2 and 9 of culture. Statistical analysis of electrophysiological signal amplitude d and firing rate e in the bradyarrhythmia model. N = 82 (N represents the total number of measured channels); *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. f Poincaré plots analysis of the bradyarrhythmia model. The horizontal axis (ISIn) represents the interval between the current and the previous extracellular action potential, and the vertical axis (ISIn+1) represents the interval between the current and the next extracellular action potential Fig. 3c illustrates typical electrophysiological signals of cardiomyocytes cultured on three different devices. On day 2 of culture, cardiomyocytes exhibit spontaneous and rhythmic extracellular electrophysiological signals with relatively low amplitude. From day 4 to day 8, both the signal firing rate and amplitude remain stable. However, the firing rate decreases significantly and exhibits irregularities on day 9, showing a tendency toward bradyarrhythmia. To further clarify the establishment time of the bradyarrhythmia model, we perform a statistical analysis of the data. As shown in Fig. 3d, the signal amplitude continues to increase from day 2 to day 6, but significantly decreases at day 9. Meanwhile, statistical analysis (Fig. 3e) shows that the firing rate remains relatively stable (1.01–1.33 Hz) from days 4 to 8, but decreases significantly to approximately 52% of day 8 by day 9, suggesting a potential decline in cellular activity or overall cell health. Furthermore, signal intervals are extracted, calculated, and subsequently analyzed using Poincaré plots to investigate the firing rate characteristics of cardiomyocytes. As depicted in Fig. 3f, the data points in the Poincaré plots of cardiomyocytes cultured for days 2–8 are distributed along a straight line with a slope of 1, indicating consistent signal intervals and stable rhythm. Nevertheless, the disordered distribution of data points on day 9 suggests irregular signal intervals, which is one of the important features of bradyarrhythmia. Therefore, cardiomyocytes cultured for 9 days are identified for the establishment of the bradyarrhythmia model used in subsequent NPT experiments. Precise temperature regulation in nanoplasmonic photothermal therapy The temperature of NPT significantly influences the nanoplasmonic photothermal effect, thereby determining the therapeutic efficacy for bradyarrhythmia. To evaluate the effect of NPT on bradyarrhythmia, the treatment temperature is precisely adjusted to 38, 38.5, and 39 °C using the regulation system (Figs. 4a and S5). Figure 4b demonstrates the average time required for Au NR-mediated NPT to reach 38, 38.5, and 39 °C, which are 50.14 s, 62.31 s, and 118.68 s, respectively. In the bradyarrhythmia model, NIR-induced temperatures of 38, 38.5, and 39 °C restored the rhythmicity (Fig. 4c). Notably, the duration of cardiomyocyte rhythm recovery is longest at 38.5 °C, which may be attributed to the insufficient treatment temperature at 38 °C and the potential cellular damage at 39 °C. To further assess the therapeutic effect, we conduct statistical analyses of electrophysiological signals recorded by multiple electrodes before and after irradiation. Line plots (grey) are generated to depict the relative changes in amplitude (Fig. 4d–f) and firing rate (Fig. 4g–i) after treatment compared with pre-treatment levels. The results indicate that signal amplitude after treatment remains almost consistent with the pre-treatment values (Fig. 4d–f). Meanwhile, after 1 h of treatment at 38.5 °C, the firing rate exhibits an increasing trend and stabilizes at approximately 117% of the pre-treatment level, whereas fluctuations are observed at 38 °C and 39 °C (Fig. 4g–i). Additionally, statistical histograms confirm that there is no significant difference in electrophysiological signal amplitude before and after treatment (Fig. 4j). Notably, compared to pre-treatment levels, the post-treatment firing rate shows a 2.05-fold increase at 38 °C and 38.5 °C, and a 1.21-fold increase at 39 °C (Fig. 4k). Under the NIR laser irradiation at 38.5 °C, the recovery duration of cardiomyocytes reaches 380.0 min (Fig. 4l), which is considerably higher than that observed at 38 °C (153.3 min) and 39°C (113.3 min), demonstrating its remarkable benefits in the treatment of bradyarrhythmia.Fig. 4Precise temperature regulation in NPT.a Schematic diagram of the NPT temperature regulation via RTS. b Time required to reach target temperatures of 38, 38.5, and 39 °C for Au NRs-mediated NPT. c Typical electrophysiological signals of cardiomyocytes before and after irradiation at different temperatures (38, 38.5, and 39 °C). Statistical analysis of the relative changes in amplitude d–f and firing rate g–i in electrophysiological signals recorded by multiple electrodes at different treatment temperatures (38, 38.5, and 39 °C). For each temperature, changes in amplitude and firing rate measured from the same electrode before and after treatment are represented by a grey line. j Statistical histograms of amplitude before and after treatment at different temperatures (38, 38.5, and 39 °C). k Statistical histograms of firing rate before and after treatment at different temperatures (38, 38.5, and 39 °C) (N ≥ 93, N represents the total number of measured channels). l Statistical analysis of the recovery duration after irradiation at various temperatures (38, 38.5, and 39 °C). Mean values are indicated above the error bars in the bar chart. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Precise temperature regulation in NPT. a Schematic diagram of the NPT temperature regulation via RTS. b Time required to reach target temperatures of 38, 38.5, and 39 °C for Au NRs-mediated NPT. c Typical electrophysiological signals of cardiomyocytes before and after irradiation at different temperatures (38, 38.5, and 39 °C). Statistical analysis of the relative changes in amplitude d–f and firing rate g–i in electrophysiological signals recorded by multiple electrodes at different treatment temperatures (38, 38.5, and 39 °C). For each temperature, changes in amplitude and firing rate measured from the same electrode before and after treatment are represented by a grey line. j Statistical histograms of amplitude before and after treatment at different temperatures (38, 38.5, and 39 °C). k Statistical histograms of firing rate before and after treatment at different temperatures (38, 38.5, and 39 °C) (N ≥ 93, N represents the total number of measured channels). l Statistical analysis of the recovery duration after irradiation at various temperatures (38, 38.5, and 39 °C). Mean values are indicated above the error bars in the bar chart. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 To elucidate the molecular mechanism underlying temperature-dependent therapeutic effects during photothermal therapy, several studies have performed mRNA sequencing on cardiomyocytes following treatment31,33. Photothermal therapy can modulate the expression levels of multiple key ion channel genes, thereby significantly enhancing the electrophysiological activity of cardiomyocytes. These genes include those encoding voltage-gated potassium channels (e.g., KCNH2, KCNH1, KCNJ8, and KCNQ1), calcium-activated potassium channels (e.g., KCNN4), subunits of voltage-gated calcium channels (e.g., CACNA1S, CACNA1C, CACNA2D1, CACNB3, and CACNA2D2), as well as genes encoding sodium channel-associated proteins (e.g., SCN1B, SCN3B, and SCN5A)31,33. Notably, KCNJ8 encodes the Kir6.1 subunit, a key regulator of the resting membrane potential and action potential repolarization that is crucial for cardiomyocyte excitability. CACNA1C encodes theα1C subunit (Cav1.2) of the L-type calcium channel, a core component of excitation-contraction coupling in cardiomyocytes that mediates calcium ion influx and subsequently triggers sarcoplasmic reticulum calcium release and myocardial contraction. Therefore, NPT enhances the electrophysiological activity of cardiomyocytes in bradyarrhythmia by modulating the functional state of ion channels. Optimization of temperature regulation strategies in nanoplasmonic photothermal therapy Precise temperature regulation is a critical parameter for enhancing the therapeutic effect of NPT. Two distinct temperature sensing strategies, including RTS-based and image-based (ITS-based) temperature sensing, are employed to regulate the temperature of NPT for bradyarrhythmia (Fig. 5a). The RTS-based strategy utilizes serpentine-shaped RTSs with 24 windings and a line width and spacing of 4 μm. By interfacing directly with cardiomyocytes, the RTS accurately reflects the local temperature changes under NIR irradiation while effectively minimizing interference from the culture environment. This enables precise temperature regulation within ± 0.1 °C and supports millisecond-level real-time response. Concurrently, the integrated MEA records dynamic electrophysiological signals before and after treatment, allowing for a comprehensive assessment of therapeutic effects. The ITS-based strategy involves the placement of an NIR thermal imager at the same level as the NIR laser to monitor the temperature during treatment. This system provides real-time temperature monitoring as well as visualization of the thermal distribution within the treatment area. With an exposure time of 5 min for the NIR laser, this method allows for effective photothermal treatment of bradyarrhythmia. As shown in Fig. 5b, the electrophysiological signals are slow and arrhythmic before treatment, whereas the firing rate after irradiation increases significantly and is restored to a normal rhythmic state. Specifically, as the NPT temperature is regulated to 38.5 °C using RTS (Fig. 5b(i)), the cardiomyocytes return to the normal rhythm from bradyarrhythmia. Similarly, rhythm recovery can also be achieved through an ITS-based strategy by applying 1.0 W/cm² NIR laser irradiation for 5 min (Fig. 5b(ii)). As illustrated in Figs. 5c, d, the Poincaré plot data points of cardiomyocytes before treatment are disordered, whereas those after treatment are distributed along a straight line with a slope of 1, indicating that the NPT significantly enhances the consistency of the electrophysiological signal intervals. Moreover, statistical analysis reveals that the normal rhythm recovery duration in NPT regulated by RTS-based sensing (380.0 min) amounts to 133.8% of that achieved with ITS-based temperature sensing (284.0 min) (Fig. 5e), highlighting the critical importance of precise temperature regulation in maintaining the therapeutic effect.Fig. 5Optimization of temperature regulation strategies in NPT.a Schematic illustration of RTS-based and imaging-based temperature (ITS-based) sensing strategies for Au NRs-mediated NPT. b Typical electrophysiological signals of cardiomyocytes before and after NIR laser irradiation. Photothermal treatment is performed based on (i) RTS-based and (ii) ITS-based temperature sensing strategies. The inset shows an enlarged view of the electrophysiological signal in the dashed area. c Poincaré plots of firing rate characteristics before and after irradiation, which are regulated by the RTS-based temperature sensing strategy. d Poincaré plots of firing rate characteristics before and after irradiation with temperature regulated by an ITS-based sensing strategy. e Statistical analysis of the recovery duration under different temperature sensing strategies. Mean values are indicated above the bar chart Optimization of temperature regulation strategies in NPT. a Schematic illustration of RTS-based and imaging-based temperature (ITS-based) sensing strategies for Au NRs-mediated NPT. b Typical electrophysiological signals of cardiomyocytes before and after NIR laser irradiation. Photothermal treatment is performed based on (i) RTS-based and (ii) ITS-based temperature sensing strategies. The inset shows an enlarged view of the electrophysiological signal in the dashed area. c Poincaré plots of firing rate characteristics before and after irradiation, which are regulated by the RTS-based temperature sensing strategy. d Poincaré plots of firing rate characteristics before and after irradiation with temperature regulated by an ITS-based sensing strategy. e Statistical analysis of the recovery duration under different temperature sensing strategies. Mean values are indicated above the bar chart Conclusions and perspective In this work, we develop an integrated, precise temperature regulation and simultaneous electrophysiological detection platform to investigate the therapeutic effects of Au NR-mediated NPT on cardiac bradyarrhythmia. The serpentine-shaped RTSs enable precise temperature measurement during NPT, while MEA dynamically records the electrophysiological signals of cardiomyocytes before and after treatment. Through optimization of the RTS structural parameters, we found that the configuration with 24 windings, a 4 μm line width, and a 4 μm spacing possesses excellent temperature response sensitivity. When the NPT temperature is precisely regulated to 38.5 °C, bradyarrhythmia is restored to normal rhythm and maintains a long-term recovery duration of 380 min. Compared to the ITS-based temperature sensing strategy (284 min), the RTS-based sensing strategy developed in this study achieves more precise thermal regulation, which allows treated bradyarrhythmia cardiomyocytes to maintain a normal rhythm for a longer time. This study proposes an integrated regulating-sensing platform that combines precise temperature regulation with dynamic electrophysiological signal detection, demonstrating the crucial role of precision temperature in NPT for cardiac bradyarrhythmia and opening up new avenues for optimizing photothermal therapeutic strategies. Besides, the system holds broad potential for in vitro research, such as: (i) detecting heat-production changes during cell proliferation, differentiation, or metabolic processes41,45,46; (ii) measuring micro‑calorimetric in drug stimulation or biological reaction processes46,47; (iii) investigating energy metabolism and thermal signals in single-cell or micro-scale systems48. Furthermore, the integrated RTS-MEA device developed here is promising for mass production and integration with flexible substrates. The fabrication process employs standard microfabrication techniques (e.g., photolithography, sputtering, lift-off, and SU-8 insulation), which are compatible with wafer-level batch manufacturing, thereby laying a solid foundation for high-yield and high-reliability manufacturing. In the future, systematic optimization of fabrication parameters, combined with the introduction of automated manufacturing and detection systems, is expected to realize effective large-scale device fabrication49. The spatially separated yet functionally coordinated design of the RTS and MEA substantially simplifies integration complexity. Subsequent efforts could focus on exploring the integration of the RTS-MEA with biocompatible polymeric materials (e.g., polydimethylsiloxane or polyimide) to enable soft, conformal bioelectronic systems for advanced cardiac therapeutic monitoring. As the continuous in-depth research on NPT for bradyarrhythmia, NPT is expected to develop into a safer and more effective strategy for bradyarrhythmia treatment. Further optimization of temperature-responsive nanomaterials and improvement of therapeutic targeting will promote the transformation of NPT from basic research to clinical application, and provide innovative treatment ideas and research directions for the field of cardiology. Supplementary information Supporting information Supporting information